Pacific Biosciences of Californ

PACB · Healthcare

$1.28

Κεφαλαιοποίηση: 397.86M USDΜερισματική απόδοση: —
AdvanceΕίναι καλή στιγμή να αγοράσεις Pacific Biosciences of Californ; Ρώτα το Copenvest AIΠάρε μια Advance AI άποψη για timing, ρίσκο και τι κάνουν οι παρακολουθούμενοι επενδυτές.Ρώτα το Copenvest AI

Φόρτωση γραφήματος…

Νέα

Τελευταίοι τίτλοι για αυτή τη μετοχή

GlobeNewswire Inc.6 Αυγ 2026, 2:52 μ.μ.

AI Disruption Reshapes Bioinformatics: Record Investment and Breakthrough Tools Signal a New Era for Drug Discovery and Precision Medicine

Artificial intelligence is fundamentally restructuring bioinformatics, compressing drug discovery timelines and attracting billions in venture capital. AI tools like AlphaFold and generative biology platforms are delivering measurable ROI, with companies achieving 99% cost reductions in drug discovery. North America leads adoption, supported by federal programs and substantial R&D investments from established life sciences players.